Stay updated with breaking news from Otsuka Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brand pharma companies invest valuable resources, time, and money in moving drugs from development to FDA approval. The new drug approval may also enjoy some type of FDA exclusivity.
Echelon Capital Markets analyst Stefan Quenneville in a recent report reiterated a “Speculative Buy” rating on Mindset Pharma stock.
Echelon Capital Markets analyst Stefan Quenneville reiterated a “Speculative Buy” rating and $1.25 target price on Mindset Pharma in a Wednesday report to clients.
Through apps, pharmaceutical companies can actually influence patient adherence and mindset after that patient has been prescribed that company's medication by their physician.
Reasons to buy: Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Classify potential new clients or partners in the target demographic. Develop tactical initiatives by understanding the focus areas of leading companies. Plan mergers and acquisitions meritoriously by identifying Top Manufacturer. Formulate corrective measures for pipeline projects by understanding Schizophrenia Drugs pipel...